PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers model familial amyloidosis in vitro using iPSC technology

2013-10-31
(Press-News.org) Contact information: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Researchers model familial amyloidosis in vitro using iPSC technology (Boston) -- Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have generated the first known disease-specific induced pluripotent stem cell (iPSC) lines from a patient with familial transthyretin amyloidosis (ATTR). The findings, which are reported in Stem Cell Reports, may lead to new treatments for genetic diseases such as familial amyloidosis.

iPSCs are a form of stem cells that come from skin or blood cells reprogrammed into cells that have the ability to become any type of tissue in the body. ATTR is a lethal, autosomal dominant protein-folding disorder caused by one of more than 100 distinct mutations in the transthyretin (TTR) gene. In ATTR, protein secreted from the liver aggregates and forms fibrils in target organs, chiefly the heart and peripheral nervous system, highlighting the need for a model capable of duplicating the multisystem complexity of this clinically variable disease.

According to researchers using iPSC technology, cell lines can be established that are genetically identical to the individual from whom they are derived, allowing for disease modeling and development of novel therapeutics in the personalized genetic context of the patient from which they are made.

In this study, the researchers used the iPSC to generate liver cells that secrete the disease-specific mutant protein as well as cardiac and neuronal cells, the downstream target tissues of the disease. Upon exposure to the mutant protein, the heart and neuronal cells displayed signs of stress and an increased level of cell death as compared to those exposed to normal protein, thereby recreating essential aspects of the disease in vitro. Furthermore, small molecule stabilizers of the mutant protein that are being tested in clinical trials show efficacy in this model, validating this iPSC-based, patient-specific in vitro system as a platform for testing therapeutic strategies.

"Our work demonstrates that it is possible to model a complex, multisystem genetic disease in a relatively short space of time, using lineage-specified cells derived from patient stem cells," explained George J. Murphy, PhD, assistant professor of medicine in the section of Hematology and Oncology and co-director of the Center for Regenerative Medicine (CReM) at BUSM and BMC.

"This is a major breakthrough that will facilitate testing novel targeted therapies that are being developed for ATTR amyloidosis," said coauthor John Berk, MD, clinical director of the Amyloidosis Center at BUSM and BMC, where these rare diseases have been studied for more than 50 years. "Patients and families from all over the world who come to us for treatment may soon benefit from this research."

### Funding for the study was provided by the Amyloidosis Foundation, the Young Family Amyloid Research Fund and the Boston University Clinical and Translational Science Institute.


ELSE PRESS RELEASES FROM THIS DATE:

Study gives Catholic schools poor marks

2013-10-31
Study gives Catholic schools poor marks EAST LANSING, Mich. — A national study led by a Michigan State University economist suggests Catholic schools are not superior to public schools after all. Math scores for Catholic students dropped between kindergarten and eighth ...

Suzaku study points to early cosmic 'seeding'

2013-10-31
Suzaku study points to early cosmic 'seeding' Most of the universe's heavy elements, including the iron central to life itself, formed early in cosmic history and spread throughout the universe, according to a new study of the Perseus Galaxy Cluster ...

Researchers discover how retinal neurons claim the best brain connections

2013-10-31
Researchers discover how retinal neurons claim the best brain connections Discovery may shed light on brain disease, development of regenerative therapies Real estate agents emphasize location, location, and – once more for good measure – location. It's the same in a developing brain, ...

Simple plants aren't always easy: Revision of the liverwort Radula buccinifera complex

2013-10-31
Simple plants aren't always easy: Revision of the liverwort Radula buccinifera complex The supposedly widespread and variable Australasian liverwort species Radula buccinifera is nothing of the kind. The species was described in 1844, and reported for New Zealand in 1855. ...

Danish research provides new knowledge about the body's fight against HIV

2013-10-31
Danish research provides new knowledge about the body's fight against HIV When a person is infected with HIV the virus infects the cells of the immune system. From here the virus spreads around the body, while at the same time breaking down important ...

Patient in 'vegetative state' not just aware, but paying attention

2013-10-31
Patient in 'vegetative state' not just aware, but paying attention Research raises possibility of devices in the future to help some patients in a vegetative state interact with the outside world A patient in a seemingly vegetative state, unable to move or ...

Defective nanotubes turned into light emitters

2013-10-31
Defective nanotubes turned into light emitters UPV/EHU-University of the Basque Country researchers have developed and patented a new source of light emitter based on boron nitride nanotubes and suitable for developing high-efficiency optoelectronic devices This news ...

Scent marking

2013-10-31
Scent marking The mammalian equivalent of showy plumage Many animals use scent marking to advertise their territory – they urinate at strategic locations – to communicate their social status and ownership. It has ...

Research identifies ways to improve access to mental health services

2013-10-31
Research identifies ways to improve access to mental health services A study by researchers from the Universities of Liverpool and Manchester has identified ways to improve how older people and ethnic minority populations access mental health care services. As ...

Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant

2013-10-31
Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant DETROIT – New drug therapies offer promise to some hepatitis C sufferers whose transplanted livers are threated by a recurrence of the disease, including some ...

LAST 30 PRESS RELEASES:

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

More scrutiny of domestic fishing fleets at ports could help deter illegal fishing

Scientists transform plastic waste into efficient CO2 capture materials

Discovery of North America’s role in Asia’s monsoons offers new insights into climate change

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

Researchers discover massive geo-hydrogen source to the west of the Mussau Trench

Even untouched ecosystems are losing insects at alarming rates, new study finds

Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures

MD Anderson research highlights for September 5, 2025

Physicists create a new kind of time crystal that humans can actually see

Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions

Understanding orderly and disorderly behavior in 2D nanomaterials could enable bespoke design, tailored by AI

JAMA Network launches JAMA+ Women's Health

Surface plasmon driven atomic migration mediated by molecular monolayer

ERC Starting Grant for five University of Groningen scientists

AI turns printer into a partner in tissue engineering

What climate change means for the Mediterranean Sea

[Press-News.org] Researchers model familial amyloidosis in vitro using iPSC technology